Journal of Genetic Counseling

, Volume 18, Issue 2, pp 137–146 | Cite as

Consumers’ Desire towards Current and Prospective Reproductive Genetic Testing

  • Feighanne HathawayEmail author
  • Esther Burns
  • Harry Ostrer
Original Research


As our knowledge and abilities in molecular genetics continues to expand, so does our ability to detect certain conditions/traits prenatally; however, it is unknown if this increase in scientific ability will be utilized by the consumers of genetic services. Our study gauges the consumers’ opinion towards reproductive testing for diseases and enhancements. Prior to their initial visit with a genetic counselor, patients were asked to participate in a survey. These consumers were asked to indicate traits and conditions for which they would choose reproductive genetic testing. The majority of respondents would elect to have prenatal genetic testing for mental retardation (75%), deafness (54%), blindness (56%), heart disease (52%), and cancer (51%). Our results indicated that 49.3% would choose testing for a condition that resulted in death by 5 years of age, whereas only 41.1%, 24.9%, and 19% would choose testing for conditions that results in death by 20, 40, and 50 years of age, respectively. Most respondents did not desire testing for enhancements (e.g. 13% would choose testing for superior intelligence). Our study suggests that consumers desire more reproductive genetic testing than what is currently offered; however, their selection of tests suggests self-imposed limits on testing.


Genetic Testing Attitude Reproductive Screening 


  1. Alsulaiman, A., & Hewison, J. (2007). Attitudes to prenatal testing and termination of pregnancy in Saudi Arabia. Community Genetics, 10(3), 169–173. doi: 10.1159/000101758.PubMedCrossRefGoogle Scholar
  2. Anido, A., Carlson, L. M., Taft, L., & Sherman, S. L. (2005). Women’s attitude toward testing for Fragile X carrier status: a qualitative analysis. Journal of Genetic Counseling, 14(4), 295–306. doi: 10.1007/s10897-005-1159-6.PubMedCrossRefGoogle Scholar
  3. Austin, J., Smith, G., & Honer, W. (2006). The genomic era and perceptions of psychotic disorders: genetic risk estimation, associations with reproductive decisions and views about predictive testing. American Journal of Medical Genetics, 141B, 926–928. doi: 10.1002/ajmg.b.30372.PubMedCrossRefGoogle Scholar
  4. Boué, J., Muller, F., Simon-Bouy, B., Faure, C., & Boué, A. (1991). Consequences of prenatal diagnosis of cystic fibrosis on the reproductive attitudes of parents of affected children. Prenatal Diagnosis, 11, 209–214. doi: 10.1002/pd.1970110402.PubMedCrossRefGoogle Scholar
  5. Brunger, J. W., Murray, G. S., O’Riordan, M., Matthews, A. L., Smith, R. J., & Robin, N. H. (2000). Parental attitudes toward genetic testing for pediatric deafness. American Journal of Human Genetics, 67(6), 1621–1625, Dec.PubMedCrossRefGoogle Scholar
  6. Campbell, E., & Ross, L. F. (2004). Attitudes of healthcare professionals and parents regarding genetic testing for violent traits in childhood. Journal of Medical Ethics, 30(6), 580–586. doi: 10.1136/jme.2003.005389.PubMedCrossRefGoogle Scholar
  7. Case, A., Ramadhani, T. A., Canfield, M. A., & Wicklund, C. A. (2007). Awareness and attitudes regarding prenatal testing among Texas women of childbearing age. Journal of Genetic Counseling, 16(5), 551–664. doi: 10.1007/s10897-007-9103-6.CrossRefGoogle Scholar
  8. Conway, S. P., Allenby, K., & Pond, M. N. (1994). Patient and parental attitudes toward genetic screening and its implications at an adult cystic fibrosis centre. Clinical Genetics, 45, 308–312.PubMedCrossRefGoogle Scholar
  9. Creighton, S., Almqvist, E. W., MacGregor, D., Fernandez, B., Hogg, H., Beis, J., et al. (2003). Predictive, pre-natal and diagnostic testing for Huntington disease: the experience in Canada from 1987–2000. Clinical Genetics, 63, 462–475. doi: 10.1034/j.1399-0004.2003.00093.x.PubMedCrossRefGoogle Scholar
  10. Dyson, F. (2007). Our biotech future. The New York Review of Books, 54, 4–8.Google Scholar
  11. Eng, C. M., et al. (1997). Prenatal genetic carrier testing using triple disease screening. Journal of the American Medical Association, 278(15), 1268–1272. doi: 10.1001/jama.278.15.1268.PubMedCrossRefGoogle Scholar
  12. Gason, A. A., et al. (2003). Evaluation of a Tay Sachs Disease Screening Program. Clinical Genetics, 63(5), 386–392. doi: 10.1034/j.1399-0004.2003.00074.x.PubMedCrossRefGoogle Scholar
  13. Harmon, A. (2004a). As gene test menu grows, who gets to choose? The New York Times, July 21.Google Scholar
  14. Harmon, A. (2004b). Burden of knowledge: tracking prenatal health; In New Tests for Fetal Defects, Agonizing Choices for Parents. The New York Times, June 20.Google Scholar
  15. Harmon, A. (2004c) Neurodiversity forever; the disability movement turns to brains. The New York Times, May 9.Google Scholar
  16. Harmon, A. (2005). The problem with an almost perfect genetic world. The New York Times, November 20.Google Scholar
  17. Hayden, M. R. (2000). Predictive testing for Huntington disease: the calm after the storm. Lancet, 356, 1944–1945. doi: 10.1016/S0140-6736(00)03301-8.PubMedCrossRefGoogle Scholar
  18. Henneman, L., et al. (2001). Attitudes towards reproductive issues and carrier testing among adult patients and parents of children with cystic fibrosis (CF). Prenatal Diagnosis, 21(1), 1–9. doi: 10.1002/1097-0223(200101)21:1<1::AID-PD9671::AID-PD967>3.0.CO;2-#.PubMedCrossRefGoogle Scholar
  19. Hewison, J., et al. (2007). Attitudes to prenatal testing and termination of pregnancy for fetal abnormality: a comparison of white and Pakistani women in the UK. Prenatal Diagnosis, 27(5), 419–430. doi: 10.1002/pd.1701.PubMedCrossRefGoogle Scholar
  20. Hudson, K., et al. (2004). Reproductive genetic testing: what America thinks. Genetics and Public Policy Center. Available at: Accessed May 20, 2007.
  21. Jones, I., Scourfield, J., McCandless, F., & Craddock, N. (2002). Attitudes towards future testing for bipolar disorder susceptibility genes: a preliminary investigation. Journal of Affective Disorders, 71, 189–193. doi: 10.1016/S0165-0327(00)00384-0.PubMedCrossRefGoogle Scholar
  22. Kessler, S., Field, T., Worth, L., & Mosbarger, H. (1987). Attitudes of persons at risk for Huntington disease toward predictive testing. American Journal of Medical Genetics, 26, 259–270. doi: 10.1002/ajmg.1320260204.PubMedCrossRefGoogle Scholar
  23. Kronn, D., Jansen, V., & Ostrer, H. (1998). Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY. Archives of Internal Medicine, 158(7), 777–781.PubMedCrossRefGoogle Scholar
  24. Lima, M., Kay, T., Vasconcelos, J., et al. (2001). Disease knowledge and attitudes toward predictive testing and prenatal diagnosis in families with Machado–Joseph disease from Azores Islands (Portugal). Community Genetics, 4(1), 36–42. doi: 10.1159/000051154.PubMedCrossRefGoogle Scholar
  25. Markel, D. S., Young, A. B., & Penney, J. B. (1987). At-risk persons’ attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan. American Journal of Medical Genetics, 26, 295–305. doi: 10.1002/ajmg.1320260207.PubMedCrossRefGoogle Scholar
  26. Mastromauro, C., Myers, R. H., & Berkman, B. (1987). Attitudes toward presymptomatic testing in Huntington disease. American Journal of Medical Genetics, 26, 271–282. doi: 10.1002/ajmg.1320260205.PubMedCrossRefGoogle Scholar
  27. Meissen, G. J., & Berchek, R. L. (1987). Intended use of predictive testing by those at risk for Huntington disease. American Journal of Medical Genetics, 26, 283–293. doi: 10.1002/ajmg.1320260206.PubMedCrossRefGoogle Scholar
  28. Milner, K., Collins, E., Connors, G., & Petty, E. (1998). Attitudes of young adults to prenatal screening and genetic correction for human attributes and psychiatric conditions. American Journal of Medical Genetics, 76, 111–119. doi: 10.1002/(SICI)1096-8628(19980305)76:2<111::AID-AJMG2>3.0.CO;2-W.PubMedCrossRefGoogle Scholar
  29. Milner, K., Han, T., & Petty, E. (1999). Support for the availability of prenatal testing for neurological and psychiatric conditions in the psychiatric community. Genetic Testing, 3(3), 279–286. doi: 10.1089/109065799316590.PubMedCrossRefGoogle Scholar
  30. Nelkin, D., & Tancredi, L. (1989). Diagnosis in the healthcare system. In Dangerous Diagnostics: The Social Power of Biological Information (pp. 51–74). New York: Basic.Google Scholar
  31. Rothman, S., & Rothman, D. (2003). The Pursuit of Perfection: The Promise and Perils of Medical Enhancement, 1st Edn. New York: Pantheon.Google Scholar
  32. Sandel, M. J. (2007). The Case against Perfection: Ethics in the Age of Genetic Engineering, 1st Edn. Cambridge: Harvard University Press.Google Scholar
  33. Toivianen, H., Jallinoja, P., Aro, A., & Hemminki, E. (2003). Medical and lay attitudes towards genetic screening and testing in Finland. European Journal of Human Genetics, 11, 565–572. doi: 10.1038/sj.ejhg.5201006.CrossRefGoogle Scholar
  34. U.S. Census Bureau. American Fact Finder, 2000. Available at: Accessed May 7, 2008.
  35. Watson, E. K., Marchant, J., Bush, A., & Williamson, B. (1992). Attitudes towards prenatal diagnosis and carrier screening for cystic fibrosis among the parents of patients in a paediatric cystic fibrosis clinic. Journal of Medical Genetics, 29, 490.PubMedGoogle Scholar

Copyright information

© National Society of Genetic Counselors, Inc. 2008

Authors and Affiliations

  • Feighanne Hathaway
    • 1
    • 2
    • 4
    Email author
  • Esther Burns
    • 3
  • Harry Ostrer
    • 1
  1. 1.Human Genetics ProgramNew York University School of MedicineNew YorkUSA
  2. 2.New York University Clinical Cancer CenterNew YorkUSA
  3. 3.Stern College for Women at Yeshiva UniversityNew YorkUSA
  4. 4.NYU Clinical Cancer CenterNew YorkUSA

Personalised recommendations